AX·NEWS
Sign in

Biotech & Medtech

Biotech & Medtech news — Monday 05 October 2026

46 stories from 5 sources, every one in English. Each links to its publisher.

Open in the live feedRSS feedOn a TV

  1. Investing in Community Health: A New Model for Safety-Net Healthcare Innovation
    USMedCity News

    Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund…

  2. Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition
    USMedCity News

    Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this…

  3. STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
    USSTAT News

    Federal appeals court judges didn’t take kindly to the Trump administration’s arguments Monday in a hearing on Humana’s lawsuit against the government over its rules for auditing Medicare Advantage plans. The country’s second largest…

  4. STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
    USSTAT News

    It is probably impossible to overstate how complex a brain is: A network of billions of intertwined neurons forming an intricate anatomy, capable of working on the millisecond scale to perceive reality, detect sensations, create plans, and…

  5. Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums
    USMedCity News

    The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs. The post Trump Administration…

  6. STAT+: New Trump regulations would clean up health care pricing disclosures
    USSTAT News

    The Trump administration released new regulations Monday that will force health insurance companies to publish cleaned-up spreadsheets of the prices that they pay hospitals and doctors, while stripping out meaningless data that clogged up…

  7. STAT+: Prices, prices, prices
    USSTAT News

    This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here . Hi! Would you drive a microcar ? It seems like the perfect errand vehicle, but it still costs as much as an outpatient surgery. As you’ll see…

  8. STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
    USSTAT News

    Utah regulators on Monday announced a plan to allow an artificial intelligence product to evaluate patients for acne treatment and write new drug prescriptions without prior human review. A startup called Nolla Health will launch an…

  9. Shionogi pays $2B to acquire a rare disease startup
    USBioPharma Dive

    The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.

  10. Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
    USBioPharma Dive

    The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicine.

  11. STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
    USSTAT News

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. I’m hanging out with my 8-year-old pal, Silas Mirza-Ladd, who wants to be featured in a newspaper one day. So…

  12. Vaxcyte skyrockets on ‘near best-case’ pneumococcal vaccine data
    USBioPharma Dive

    The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer and Merck on nearly all bacterial strains in the first of three Phase 3 trials.

  13. STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
    USSTAT News

    Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating. Now, though, that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance. You knew…

  14. The Biggest Healthcare Fix Might Not Come From a Vendor
    USMedCity News

    Nobody has ever needed convincing on what to fix. What they’ve lacked is a way to act on it themselves, in something close to real time instead of on a vendor’s roadmap. The post The Biggest Healthcare Fix Might Not Come From a Vendor…

  15. STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
    USSTAT News

    Vaxcyte said Monday that its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the California-based biotech to compete with Pfizer and Merck. Vaxcyte’s shot, VAX-31, is designed to protect…

  16. Could we one day vaccinate against every cancer?
    USSTAT News

    Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . The winner of the Nobel Prize for medicine was announced early this morning. Did you win your office pool? Do you think…

  17. Strengthening Dental Payment Integrity Through Smarter Claim Editing
    USMedCity News

    [Sponsored] Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing practices drive unnecessary costs and weaken payment integrity. For dental payers, the stakes extend beyond…

  18. 2026 Nobel Prize in Medicine awarded for brain research tool called optogenetics
    USSTAT News

    Karl Deisseroth, Peter Hegemann, and Georg Nagel are the joint recipients of the 2026 Nobel Prize in Physiology or Medicine “for their discoveries concerning light-gated ion channels and optogenetics,” the Karolinska Institutet in…

  19. Precision for All: Closing the gap between innovation and impact
    USBioPharma Dive

    Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.

  20. How AI is transforming biopharma manufacturing facilities of the future
    USBioPharma Dive

    As AI accelerates drug discovery, here are the ways pharmaceutical manufacturing facilities are adapting.

  21. Hospital and pharmaceutical prices are smothering America’s businesses
    USSTAT News

    Workers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care industry’s high and inscrutable prices. Health insurers don’t set their premiums in a vacuum. The biggest factor is the care…

  22. Opinion: Will Claude ever win a Nobel Prize for medicine?
    USSTAT News

    On Monday morning, the Nobel Prize for medicine was announced . This year, I wonder: Will Claude or a future artificial intelligence agent ever win the most prestigious award for medical discovery? Imagine a future AI agent responding to a…

  23. Opinion: Energy drinks’ new college sports partnerships make them more dangerous than ever
    USSTAT News

    In a single generation, energy drinks have conquered the beverage world. Starting as an upscale version of the humble NoDoz pill, then sugared up for guzzling, they are now the caffeine jolt of choice for the sluggish and the…

  24. STAT+: Are stem cells the next peptides? These advocates think RFK Jr. could make it happen
    USSTAT News

    WASHINGTON — Stem cell entrepreneur Chuck Meeker is bullish about his industry’s prospects with the Food and Drug Administration nowadays. “If I were a betting man, I would say before the end of the year we have a series of FDA roundtables…

  25. STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
    USSTAT News

    The recent success of a late-stage mRNA cancer vaccine , showing the drug stopped the return of melanoma, has boosted hopes that the approach can be successfully harnessed to attack other cancers. The question now is which ones — and…

  26. FrugalEvo: Towards Cost-Aware LLM-Guided Program Evolution
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03675v1 Announce Type: new Abstract: LLM-guided evolutionary methods, such as AlphaEvolve, have emerged as powerful approaches for challenging computational optimization problems, such as circle packing. However, prior work…

  27. Continual Reinforcement Learning with Neuroevolution
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.01583v2 Announce Type: replace Abstract: Despite many studies about causes and remedies of plasticity loss in Reinforcement Learning (RL) under continual task changes, no RL method has yet consistently achieved a good balance…

  28. Small universal multiset reaction systems
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03021v1 Announce Type: new Abstract: This paper presents a construction of a small universal machine within the framework of Multi-set Reaction Systems. We encode the machine state using elements that represent registers and…

  29. Embodied Neurocomputation: A Framework for Interfacing Biological Neural Cultures with Scaled Task-Driven Validation
    USarXiv cs.NE (Neural/Bio)

    arXiv:2605.13315v2 Announce Type: replace-cross Abstract: Biological neural networks (BNNs) have been established as a powerful and adaptive substrate that offer the potential for incredibly energy and data efficient information processing…

  30. Temporal Geometry of Deep Networks: Hyperbolic Representations of Training Dynamics for Intrinsic Explainability
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03000v1 Announce Type: cross Abstract: Intrinsic explainability remains a challenging problem, particularly in contexts where multilayer perceptrons (MLPs) require dynamic re-training within an optimization environment. This…

  31. Operator Calculus for Population-Based Optimization: Modular Convergence and Finite-Population Guarantees
    USarXiv cs.NE (Neural/Bio)

    arXiv:2606.14289v2 Announce Type: replace-cross Abstract: Population-based optimizers combine update rules such as mutation, selection, and recombination. When one rule changes, it is often unclear which convergence guarantees survive or…

  32. Evolutionary Computation for Trustworthy AI: From Attacks and Defenses to Self-Evolving Era
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.02996v1 Announce Type: new Abstract: As Artificial Intelligence (AI) has evolved from task-specific models to foundation models and agents, the scope of trustworthy AI has expanded from model-level robustness to the reliability…

  33. Theoretical Lower Bounds on the Robustness of Deep ReLU Networks
    USarXiv cs.NE (Neural/Bio)

    arXiv:2602.18674v2 Announce Type: replace-cross Abstract: We present a theoretical study of the robustness of parameterized neural networks to random input perturbations. Specifically, we analyze local robustness by quantifying the…

  34. SEDIMA: Cross-Run Hierarchical Insight Memory for Evolutionary Search Agents
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.02361v1 Announce Type: new Abstract: Large language model (LLM)-driven evolutionary search is a powerful paradigm for automated program and algorithm discovery, yet existing systems are largely memoryless: each run explores from…

  35. Toward Controlling Biology with Language:Offline Learning of Prompt-Conditioned Interventions for Cells, Organoids, and Biobots
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.02247v1 Announce Type: cross Abstract: Artificial intelligence increasingly serves as a natural-language interface to complex technical systems, letting people accomplish sophisticated tasks by describing what they want rather…

  36. Safe and Robust Neural Policy Learning with Statistical Verification for Sim-to-Real Deployment in Robotics
    USarXiv cs.NE (Neural/Bio)

    arXiv:2608.06481v2 Announce Type: replace-cross Abstract: Synthesizing safe and robust neural controllers in simulation for reliable sim-to-real deployment remains a critical challenge in robotics. Existing learning-based methods typically…

  37. Aggregate accuracy conceals concentrated temporal vulnerability in a spiking speech classifier
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03155v1 Announce Type: new Abstract: Aggregate accuracy cannot reveal which utterances are locally vulnerable or how internal activity changes when labels remain stable. We retain every prediction for 725,070 adjacent-bin…

  38. Encoding and Decoding Temporal Signals with Spiking Bandpass Wavelets
    USarXiv cs.NE (Neural/Bio)

    arXiv:2605.09770v2 Announce Type: replace Abstract: Spike-based encodings are sparse and energy-efficient. However, previous theory for such spiking representations is largely disconnected from most signal processing literature and does…

  39. Parallel Time-Aligned Spiking Self-Attention for Consistent Integer-Valued Training and Spike-Driven Inference
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03291v1 Announce Type: new Abstract: Integer-valued leaky integrate-and-fire (I-LIF) neurons and spike firing approximation (SFA) reduce temporal training cost by representing spike trains as firing counts and normalized firing…

  40. Evolving Hybrid Quantum-Classical Architectures for Image Classification
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03220v1 Announce Type: new Abstract: Hybrid quantum classical neural networks integrate parameterized quantum circuits (PQCs) with established deep learning architectures, but their performance depends strongly on the choice of…

  41. Learning While Inferring: Local and Parallel Learning for Edge SNNs across Sensing Modalities
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03149v1 Announce Type: new Abstract: Edge intelligence requires models to sense continuously in real time and to keep adapting on-device, all under tight compute, energy, and memory budgets. Although spiking neural networks…

  42. Self-Repairing Recurrent Ensembles for Real-Time Recovery from Distribution Shift
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03249v1 Announce Type: new Abstract: Deploying a pretrained controller exposes it to conditions that are absent from its training data. Sensor drift, outright sensor failure and accumulating measurement noise all induce a…

  43. The Investment Acceleration Principle Revisited by means of a Neural Network
    USarXiv cs.NE (Neural/Bio)

    arXiv:2610.03282v1 Announce Type: new Abstract: The investment acceleration principle is a heuristic for modelling investment time series out of consumption time series. The model presented herein develops a disaggregated accelerator…

  44. Discovery and engineering of avian R2 retrotransposons for all-RNA-mediated targeted DNA integration in human cells
    GBNature Biotechnology

    Nature Biotechnology, Published online: 05 October 2026; doi:10.1038/s41587-026-03315-w Engineered retrotransposons enable site-specific DNA integration into human cells.

  45. Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes
    GBNature Biotechnology

    Nature Biotechnology, Published online: 05 October 2026; doi:10.1038/s41587-026-03334-7 RNA sequences are detected and converted directly into DNA barcodes.

  46. Behind (cell) walls
    GBNature Biotechnology

    Nature Biotechnology, Published online: 05 October 2026; doi:10.1038/s41587-026-03356-1 While mammalian delivery technologies are advancing to translation at an exceptional rate, delivery to plant tissues faces challenges, limiting their…